Site selectivity of osteoblast gene expression response to thyroid hormone localized by in situ hybridization

American Journal of Physiology - Endocrinology and Metabolism

Volumn 272, Issue 2 35-2, 1997, Pages

  Suwanwalaikorn, S ^a   Van Auken, M ^a   Kang, Moo Il ^a   Alex, S ^a   Braverman, L E ^a   Baran, D T ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

alkaline phosphatase; osteocalcin

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE REMODELING; CONTROLLED STUDY; FEMUR; GENE EXPRESSION REGULATION; HORMONAL REGULATION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINE; TISSUE SPECIFICITY;

EID: 0030893711     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.272.2.e212     Document Type: Article

References (22)

1. Allain, T. J., T. J. Chambers, A. M. Flanagan, and A. M. McGregor. Triiodothyronine stimulates rat osteoblastic bone resorption by an indirect effect. J. Endocrinol. 133: 327-331, 1992.
2. Balena, R., A. Markatos, M. Gentile, P. Masarachia, J. G. Seedor, G. A. Rodan, and M. Yamamoto. The aminobisphosphonate alendronate inhibits bone loss induced by thyroid hormone in the rat: comparison between effects on tibiae and vertebrae. Bone 14: 499-504, 1993.
3. Britto, J. M., A. J. Fenton, W. R. Holloway, and G. C. Nicholson. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 134: 169-176, 1994.
4. Cooper, D. S., M. M. Kaplan, E. C. Ridgway, F. Maloof, and G. H. Daniels. Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann. Intern. Med. 90: 164-168, 1979.
5. Faber, J., H. Perrild, and J. S. Johansen. Bone Gla protein and sex hormone binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level. J. Clin. Endocrinol. Metab. 70: 49-55, 1990.
6. Garrel, D. R., P. D. Delmas, L. Malavol, and J. Tourniare. Serum bone Gla protein: a marker of bone turnover in hyperthyroidism. J. Clin. Endocrinol. Metab. 62: 1052-1055, 1986.
7. Kasono, K., K. Sato, D. C. Han, Y. Fujii, T. Tsushima, and K. Shizume. Stimulation of alkaline phosphatase activity by thyroid hormone in mouse osteoblast-like cells (MC3T3-E1): a possible mechanism of hyperalkaline phosphatase in hyperthyroidism. Bone Miner. 4: 355-363, 1988.
8. Kurokawa, R., V. C. Yu, A. Naar, S. Kyakumoto, Z. Han, S. Silverman, M. G. Rosenfeld, and C. K. Glass. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev. 7: 1423-1435, 1993.
9. Lian, J., C. Stewart, E. Puchacz, S. Mackoviak, V. Shalhoub, D. Collart, G. Zambetti, and G. Stein. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc. Natl. Acad. Sci. USA 86: 1143-1147, 1989.
10. Lukert, B. P., J. C. Higgins, and M. M. Stoskopf. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J. Clin. Endocrinol. Metab. 62: 1056-1058, 1986.
11. Mosekilde, L., E. F. Eriksen, and P. Charles. Effects of thyroid hormone on bone and mineral metabolism. Endocrinol. Metab. Clin. N. Am. 19: 35-63, 1990.
12. Noda, M., K. Yoon, M. Thiede, R. Buenaga, M. Weiss, P. Henthorn, H. Harris, and G. A. Rodan. cDNA cloning of alkaline phosphatase from rat osteosarcoma (ROS 17/2.8) cells. J. Bone Miner. Res. 2: 161-164, 1987.
13. Ongphiphadhanakul, B., S. Alex, L. E. Braverman, and D. T. Baran. TSH-suppressive L-thyroxine therapy decreases bone density in the rat: effect of hypogonadism and calcitonin. J. Bone Miner. Res. 7: 1227-1231, 1992.
14. Ongphiphadhanakul, B., L. G. Jenis, L. E. Braverman, S. Alex, G. S. Stein, J. B. Lian, and D. T. Baran. Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function. Endocrinology 133: 2502-2507, 1993.
15. Perlman, T., P. N. Rangarajan, K. Umesono, and R. M. Evans. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 7: 1411-1422, 1993.
16. Rizzoli, R., J. Poser, and U. Burgi. Nuclear thyroid hormone receptors in cultured bone cells. Metab. Clin. Exp. 35: 71-74, 1986.
17. Sato, K., D. C. Han, Y. Fujii, T. Tsushima, and K. Shizume. Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3, 5, 3′ triiodo-L-thyronine nuclear receptors. Endocrinology 120: 1873-1881, 1987.
18. Schrader, M., K. M. Muller, and C. Carlberg. Specificity and flexibility of vitamin D signaling. J. Biol. Chem. 269: 5501-5504, 1994.
19. Suwanwalaikorn, S., B. Ongphiphadhanakul, L. E. Braverman, and D. T. Baran. Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administered in adult rats. Eur. J. Endocrinol. 134: 655-659, 1996.
20. Suwanwalaikorn, S., B. Ongphiphadhanakul, M. Van Auken, L. Braverman, and D. Baran. The differential response of femoral and vertebral bones to excessive L-thyroxine administration in rats is due to a post-receptor defect. J. Bone Miner. Res. 10: S398, 1995.
21. 3, vitamin D, and retinoid signaling. Endocrinology 135: 2375-2385, 1994.
22. 3 response. J. Biol. Chem. 266: 19363-19644, 1991.